| DAA1885 |
spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) |
Molecular |
skeletal muscle |
Mouse |
Spg20 |
11.0% Increase Gene Expression Level |
|
| DAA1886 |
structure specific recognition protein 1 |
Molecular |
skeletal muscle |
Mouse |
Ssrp1 |
3.0% Decrease Gene Expression Level |
|
| DAA1887 |
expressed sequence C78197 |
Molecular |
skeletal muscle |
Mouse |
C78197 |
16.0% Increase Gene Expression Level |
|
| DAA1888 |
VDNA-damage regulated autophagy modulator 2 |
Molecular |
skeletal muscle |
Mouse |
Dram2 |
16.0% Increase Gene Expression Level |
|
| DAA1889 |
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans) |
Molecular |
skeletal muscle |
Mouse |
Ube2g1 |
2.0% Decrease Gene Expression Level |
|
| DAA1890 |
zinc finger protein 651 |
Molecular |
skeletal muscle |
Mouse |
Zfp651 |
7.0% Increase Gene Expression Level |
|
| DAA1891 |
zinc finger, ZZ domain containing 3 |
Molecular |
skeletal muscle |
Mouse |
Zzz3 |
12.0% Decrease Gene Expression Level |
|
| DAA1940 |
Grip strength decreases |
Physiological |
skeletal muscle |
Mouse |
— |
— |
|
| DAA1943 |
Motor coordination decreases |
Physiological |
musculoskeletal system, nervous system |
Mouse |
— |
— |
|
| DAA1954 |
Interleukin-15 levels decrease in plasma and muscle |
Physiological |
plasma, muscle |
Mouse |
— |
— |
|
| DAA1974 |
Bone loss |
Physiological |
bone |
Mouse |
— |
— |
|